Axsome Therapeutics's total assets for Q1 2025 were $596.67M, an increase of 4.96% from the previous quarter. GB:0HKF total liabilities were $543.47M for the fiscal quarter, a 6.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.